Cite
Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma.
MLA
Cananzi, Ferdinando C. M., et al. “Long-Term Survival and Outcome of Patients Originally given Mycobacterium Vaccae for Metastatic Malignant Melanoma.” Human Vaccines & Immunotherapeutics, vol. 9, no. 11, Nov. 2013, pp. 2427–33. EBSCOhost, https://doi.org/10.4161/hv.25618.
APA
Cananzi, F. C. M., Mudan, S., Dunne, M., Belonwu, N., & Dalgleish, A. G. (2013). Long-term survival and outcome of patients originally given Mycobacterium vaccae for metastatic malignant melanoma. Human Vaccines & Immunotherapeutics, 9(11), 2427–2433. https://doi.org/10.4161/hv.25618
Chicago
Cananzi, Ferdinando C M, Satvinder Mudan, Mary Dunne, Nneka Belonwu, and Angus G Dalgleish. 2013. “Long-Term Survival and Outcome of Patients Originally given Mycobacterium Vaccae for Metastatic Malignant Melanoma.” Human Vaccines & Immunotherapeutics 9 (11): 2427–33. doi:10.4161/hv.25618.